Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 7, 2016; 22(9): 2818-2827
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2818
Table 4 Univariate and multivariate Cox regression analysis for gastric cancer-related survival
FactorsUnivariate
Multivariate
HR95%CIP valueHR95%CIP value
Age (yr)
≥ 58 vs < 581.0360.811-1.3240.776---
Sex
Female vs male1.0330.794-1.3450.809---
Histology
Differentiated vs undifferentiated1.6611.115-2.475< 0.0011.2610.839-1.8960.265
Borrmann type
IV vs I/II/III2.6341.726-4.018< 0.0011.8861.207-2.9480.005
Tumor status
pT3 + pT4 vs pT1 + pT23.1862.123-4.782< 0.0011.2300.667-2.2680.507
Lymph node metastasis
Yes vs no3.0982.128-4.512< 0.0011.4850.871-2.5330.147
pTNM stage
II vs I2.7131.318-5.5830.0071.8130.756-4.3500.183
III vs I6.4493.301-12.597< 0.0012.7231.941-7.8820.015
IV vs I10.6244.909-22.995< 0.0014.8491.610-14.6100.005
Vascular or neural invasion
Yes vs no1.7801.393-2.274< 0.0011.3241.023-1.7130.033
Operation method
Total gastrectomy vs Subtotal gastrectomy1.4251.113-1.8240.0051.1980.931-1.5420.159
Resection margins
R1 vs R02.0811.624-2.667< 0.0011.9041.298-2.7920.001
Chemotherapy regimens
Triplet or doublet vs singlet or none2.5221.379-4.6140.0032.3691.289-4.3560.005
Intraoperative blood loss (mL)
> 200 vs ≤ 2001.1460.718-1.8280.568---
Intraoperative blood transfusion
Yes vs No1.2370.835-1.8310.289---
Preoperative WBC count (× 109/L)
≥ 5.6 vs < 5.61.5421.204-1.9750.0011.5531.205-2.0010.001
P-leukopenia
Positive vs negtive1.4791.100-1.9880.0101.6601.226-2.2470.001